Risk associated with glucosamine and chondroitin sulfate treatment.
Borzelleca
Joseph F
JF
D000818:Animals; D002809:Chondroitin Sulfates / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005944:Glucosamine / Q000009:adverse effects*; D006801:Humans; D019055:No-Observed-Adverse-Effect Level; D018570:Risk Assessment
D002809:Chondroitin Sulfates; D005944:Glucosamine